Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure

Published:2016-10-28 Issue:5 Volume:31 Page:e253-e254
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Arenbergerova M.¹,Mrazova I.²,Horazdovsky J.³,Sticova E.⁴,Fialova A.¹,Arenberger P.¹

Affiliation:

1. Department of Dermatovenereology; Third Faculty of Medicine; Charles University; Prague Czech Republic

2. Department of Oncology and Radiotherapy; Ceske Budejovice Hospital; Ceske Budejovice Czech Republic

3. Department of Dermatovenereology; Ceske Budejovice Hospital; Ceske Budejovice Czech Republic

4. Department of Pathology; Third Faculty of Medicine; Charles University; Prague Czech Republic

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14010/fullpdf

Reference10 articles.

1. Analysis of dermatologic events in vemurafenib-treated patients with melanoma;Lacouture;Oncologist,2013

2. Severe diclofenac photoallergy in a patient treated with vemurafenib;Arenbergerova;J Eur Acad Dermatol Venereol,2016

3. Inhibition of mutated, activated BRAF in metastatic melanoma;Flaherty;N Engl J Med,2010

4. Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study;McArthur;Lancet Oncol,2014

5. Successful desensitization in a case of Stevens-Johnson syndrome due to vemurafenib;Minor;Melanoma Res,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie;Die Dermatologie;2024-05-21

2. Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy;Journal of Inflammation Research;2024-04

3. Severe lichenoid eruption due to concomitant medications following nivolumab administration;JEADV Clinical Practice;2023-06

4. Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview;Cancers;2023-02-14

5. Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature;Current Oncology;2022-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3